Related Experiment Videos

'[3H]quipazine' degradation products label 5-HT uptake sites

A W Schmidt¹, S D Hurt, S J Peroutka

¹Department of Neurology, Stanford University Medical Center, CA 94305.

European Journal of Pharmacology

|November 14, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Demographic Analysis of Industry-Sponsored Alzheimer's Disease Trial Populations in the United States.

The journal of prevention of Alzheimer's disease·2023

Variable responses of human microbiomes to dietary supplementation with resistant starch.

Microbiome·2016

Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.

The Journal of pharmacology and experimental therapeutics·2011

"Specific" [(3)H]8-OH-DPAT binding to glass fiber filter paper: Implications for the analysis of serotonin binding site subtypes.

Neurochemistry international·2010

Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species.

Journal of medicinal chemistry·2004

Use of fluorescence polarization detection for the measurement of fluopeptidetm binding to G protein-coupled receptors.

Journal of receptor and signal transduction research·2002

See all related articles